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Hypermobile Ehlers Danlos Syndrome (hEDS)
Jocelyn Akers, BSN, RN
Case Presentation
hEDS is an autosomal dominant disease 
with no known common genetic etiology 
that also exhibits locus heterogenicity and 
female sex dominance. It is part of the 
family of Ehlers Danlos Syndromes and is 
the most common Hereditary Disorder of 
Connective Tissue (HDCT) with an 
estimated population impact of 10 million 
in the US (Tinkle et al., 2017, pg. 49). 
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Conclusions
Significance to 
Authorship
EDS is estimated to affect nearly 1 in 5000 
individuals with hEDS including 80-90% of 
those diagnosed. hEDS presentation is 
found in the primary care setting, but 
despite this, the disease is poorly 
understood and underdiagnosed. This 
author’s current family tree includes the 
genetic characteristics of hEDS. Personal 
experience with diagnosis and treatment 
proved difficult and prolonged as medical 
providers have a general lack of 
understanding of this disease and hesitate 
to treat the resulting complex patient 
needs.  This scholarship is to improve 
awareness of hEDS to clinicians and
improve delivery of care.
What is hEDS?
hEDS presents in 2 forms
1.  Asymptomatic form- this form exhibits 
hypermobility but doesn’t have the severity 
of pain and dysfunction
2. Symptomatic form- This form begins in 
childhood or early adolescence and 
progresses in severity of symptoms
3 phases of disease over lifetime 
1. Hypermobile phase- presents in 
childhood. Usually seen with 
multiple dislocations and 
generalized gross and fine motor 
delays
2. Pain phase- 20-40 years of age. 
Headache, fatigue, pelvic pain often 
diagnosed as fibromyalgia
3. Stiffness Phase – joint trauma leads 
to arthritis, decreased muscle mass, 
weakness and disability (Tinkle et 
al., 2017).
Pathological 
Significance
Table 1 Signs & Symptoms Pathophysiology Nursing Care Implications
Musculoskeletal Pain, muscle weakness, myalgia, fatigue, limited mobility, spinal abnormalities and 
osteoarthritis (Tinkle et al., 2017)
Symptomatic joint hypermobility, weak joint connections lead to 
trauma and inflammation to joint articulations (Tinkle et al., 2017)
Early  recognition and diagnosis in children can have positive 
impact on interventions and disease impact over the lifetime 
(Scheper, Nicholson, Adams, Tofts, & Pacey, 2017)
Pain Acute and chronic, nociceptive muscle pain, spasms of tendon, generalized pain, 
dislocations, joint pain, loss of proprioception, GI,, GU, GYN pain, dystonia (Chopra 
et al., 2017)
See body system subtypes on this table for specific system pathologies Physiotherapy, low dose tricyclics, stress management, hormonal 
regulation, topical lidocaine, TENS, opioids are discouraged (Chopra 
et al., 2017).
Skin and Connective Tissue All characteristics present to a much lesser degree than other EDS subtypes and 
include: soft, silky velvety skin, semi-transparent, visible venous structure, 
hyperextensible and fragile skin (Tinkle et al., 2017)
Disorder of connective tissue matrix proteins, especially collagen with 
likely collagen genetic malformation (Tinkle et al., 2017)
Surgical wound healing may be delayed (Tinkle et al., 2017)
Gastrointestinal functional gastrointestinal disorders (dyspepsia, GERD, abdominal pain, 
diarrhea/constipation). Hiatal hernia, irritable bowel syndrome (Beckers et al., 
2016)
Limited studies of underlying cause, some evidence of esophageal 
dysmotility, visceral hypersensitivity (Beckers et al., 2016)
Assess and maintain optimal nutrition practices
Cardiovascular cardiovascular autonomic dysfunction: Postural tachycardia syndrome (POTS), 
neutrally mediated hypotension (NMH) orthostatic hypotension (OH) and 
orthostatic intolerance (OI) (Hakim et al., 2017)
Low resting blood pressure, limitations and absence of clinical trials, 
case control studies and population cohort studies for the hEDS 
subpopulation (Hakim et al., 2017)
Water and electrical replacement, beta adrenergic blockers, 
postural awareness (Hakim et al., 2017)
Nervous System & Spine Migraine, Chiari I Malformation, Atlantoaxial instability, Craniocervical instability, 
Segmental Kyphosis and instability, Tethered Cord Syndrome, Dystonia, 
Neuromuscular disorders, Tarlov Cyst Syndrome, acquired scoliosis, peripheral 
neuropathy, Idiopathic intracranial hypertension (Henderson et al., 2017)
lax ligamental structure and poor posture decrease spinal stability, 
instability and ligament dysfunction at the atlantoaxial and 
atlantooccipital joints, peripheral nerve connective tissue degradation, 
reduced intradermal nerve fiber density, tenacin-x deficiency, excess 
CSF production and reduced absorption (Henderson et al., 2017)
Neck bracing, physical therapy, lumbar puncture, Craniocervical 
fusion, VP shunts (Henderson et al., 2017) 
Gynecological Menorrhagia, genital mucosal dysfunction, painful intercourse (Tinkle et al., 2017) Pathophysiology poorly understood (Tinkle et al., 2017) hormonal therapy as needed, physiotherapy
Dental TMJ/TMD, limited maximal mouth opening, mucosal bleeding, temporal headache, 
bruxism (Mitakides & Tinkle, 2017)
Altered teeth morphology, high cusps and deep fissures, enamel 
hypoplasia (Mitakides & Tinkle, 2017)
Often less response to local anesthetic, key to understand 
structures to target pain management technique (Mitakides & 
Tinkle, 2017)
Psychiatric Depression, anxiety, affective disorder, hopelessness, desperation (Tinkle et al., 
2017)
Negative psych state can reduce self-care and exacerbate pain 
symptoms further (Tinkle et al., 2017)
Validate patient’s symptoms, encourage psychiatric counseling, 
cognitive behavior therapy (Tinkle et al, 20170
Pelvic & Urinary System Urinary incontinence, pelvic organ prolapses (Tinkle et al., 2017) Laxity of connective tissue in pelvic floor (Tinkle et al., 2017) kegels/physical therapy, weight management (Tinkle et al., 2017)
Immune System Mast Cell activation disorders (Seneviratne, Maitland, & Afrin, 2017) Mast cells in connective tissue hyperactivity impactive 2+ organ 
systems, MCAD connection to hEDS poorly understood but clinically 
significant (Seneviratne, Maitland, & Afrin, 2017)
Encourage exercise in spite of fatigue, Medication management 
and avoidance of triggers (Seneviratne, Maitland, & Afrin, 2017)
hEDS is a disease which impacts almost 
every body system and exhibits varying 
degrees of significance in each individual 
case. It is a complex disease with limited 
but growing understanding of multisystem 
relatedness and disease process 
connectivity.  Much more work and 
research needs to be undertaken to 
understand the complex interworking of 
this disease origin and course (Tinkle et al., 
2017). 
Please see Table 1 for specific  disease 
processes and the mechanisms of impact 
proposed for each one. 
Diagnostic Criteria
It was previously known as:
• Ehlers–Danlos syndrome Type III
• Ehlers–Danlos syndrome 
Hypermobility Type (EDS-III / EDS-
HT) and 
• Joint Hypermobility Syndrome (JHS)
Updated diagnostic criteria was 
established at the 2017 International 
Consortium on Ehlers-Danlos Syndromes 
and Related Disorders and delineates 
hEDS at a specific point on a spectrum of 
joint hypermobility. Updated criteria 
aims to facilitate scholarship and 
understanding of specific genetic 
influence and disease process. hEDS 
diagnosis requires a combination of all 
parts of the following three categories:
1) Generalized Joint hypermobility 
(often per Beighton score) 
2) Five or more classical features 
3) Absence of positive alternative 
EDS or other disqualifying 
diagnosis. (The Ehers-Danlos 
Society, 2017). 
Physical deconditioning can 
contribute to cycles of weakness and 
pain exacerbations and disability-
promote physical conditioning (Tinkle et 
al., 2017, p52)
More work needs to be done in the 
areas of research and scholarship
Primary care should focus on 
appropriate diagnosis using the updated 
diagnostic criteria and treatment should 
be directed at a multisystem, 
multidisciplinary approach (Caastori et 
al., 2017) 
Management of symptoms varies to 
differentiate between acute vs emergent 
symptoms, prevention of complications 
and management of pain (Tinkle et al., 
2017).
Figure 1. POTS- postural  orthostatic tachycardia syndrome, FGDs- functional gastrointestinal disorders, JH- joint hypermobility, GJH-
generalized joint hypermobility, L-HSD- localized hypermobility spectrum disorder, PHSD- peripheral hypermobility spectrum disorder (Castori
et al., 2017)
Those with EDS often identify with the image of a zebra. Many are young and have 
multiple health problems without an explainable diagnosis. Like Zebras, those with 
EDS each have a unique presentation to their disease.  Most healthcare providers 
are taught to look for the expected and not unexpected and can often miss this 
disease in the process (The Ehlers-Danlos Society, 2019). 
